MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells

Pathobiology

Volumn 75, Issue 5, 2008, Pages 281-287

  Martin, Valérie ^a   Jørgensen, Helle F ^b   Baur Chaubert, Audrey S ^a   Berger, Jennifer ^b   Barr, Helen ^b   Shaw, Phillip ^a   Bird, Adrian ^b   Chaubert, Pascal ^a,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

DNA methylation; Gene regulation; Methyl CpG binding domain protein

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; METHYL CPG BINDING PROTEIN 2;

ARTICLE; CANCER CELL CULTURE; COLON CANCER; DNA METHYLATION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

CARCINOMA; CELL CYCLE; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA-BINDING PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P14ARF; UP-REGULATION;

EID: 54249139623     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151708     Document Type: Article

References (28)

1. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-428.
2. Klose RJ, Bird AP: Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006;31:89-97.
3. Prokhortchouk E, Hendrich B: Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs? Oncogene 2002;21:5394-5399.
4. Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-3229.
5. INK4A transcript. Cancer Res 1995;55:2995-2997.
6. INK4A genes in colon cancer. Lab Invest 2001;81:217-229.
7. Magdinier F, Wolffe AP: Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc Natl Acad Sci USA 2001;98:4990-4995.
8. Nguyen CT, Gonzales FA, Jones PA: Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res 2001;29:4598-4606.
9. Auriol E, Billard LM, Magdinier F, Dante R: Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus. Nucleic Acids Res 2005;33:4243-4254.
10. Lin X, Nelson WG: Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells. Cancer Res 2003;63:498-504.
11. Campbell PM, Bovenzi V, Szyf M: Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo. Carcinogenesis 2004;25:499-507.
12. Pulukuri SM, Rao JS: CpG island promoter methylation and silencing of 14-3-3σ gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Oncogene 2006;25:4559-4572.
13. Shukeir N, Pakneshan P, Chen G, Szyf M, Rabbani SA: Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res 2006;66:9202-9210.
14. Sansom OJ, Berger J, Bishop SM, Hendrich B, Bird A, Clarke AR: Deficiency of Mbd2 suppresses intestinal tumorigenesis. Nat Genet 2003;34:145-147.
15. Brummelkamp TR, Bernards R, Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296:550-553.
16. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-107.
17. INK4A (MTS1) gene inactivation in testicular germ cell tumors. Am J Pathol 1997;151:859-865.
18. Gottgens B, Nastos A, Kinston S, Piltz S, Delabesse EC, Stanley M, Sanchez MJ, Ciau-Uitz A, Patient R, Green AR: Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors. EMBO J 2002;21:3039-3050.
19. Ng HH, Zhang Y, Hendrich B, Johnson CA, Burner BM, Erdjument-Bromage H, Tempst P, Reinberg D, Bird A: MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet 1999;23:58-61.
20. Wischnewski F, Friese O, Pantel K, Schwarzenbach H: Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGEA3, and MAGE-A12 gene promoters. Mol Cancer Res 2007;5:749-759.
21. INK4a and hMLH1 genes. Mol Cell Biol 2005;25:4388-4396.
22. Meehan RR, Lewis JD, Bird AP: Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 1992;20:5085-5092.
23. Fraga MF, Ballestar E, Montoya G, Taysavang P, Wade PA, Esteller M: The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res 2003;31:1765-1774.
24. Klose RJ, Sarraf SA, Schmiedeberg L, McDermott SM, Stancheva I, Bird AP: DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol Cell 2005;19:667-678.
25. Detich N, Theberge J, Szyf M: Promoter-specific activation and demethylation by MBD2/demethylase. J Biol Chem 2002;277:35791-35794.
26. Fukushige S, Kondo E, Gu Z, Suzuki H, Horii A: RET finger protein enhances MBD2-and MBD4-dependent transcriptional repression. Biochem Biophys Res Commun 2006;351:85-92.
27. Sekimata M, Homma Y: Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF. Nucleic Acids Res 2004;32:590-597.
28. Tan CP, Nakielny S: Control of the DNA methylation system component MBD2 by protein arginine methylation. Mol Cell Biol 2006;26:7224-7235.